🔗 Share this article

An everyday weight loss tablet could help individuals reduce their weight by as much as a fifth, as per a study that could pave the way for countless people more people to lose weight.

How the Drug Functions

The drug, called orforglipron, focuses on the same gut hormone receptors as slimming shots like Mounjaro and semaglutide. During research of 3,127 adults, 20% of users who used the daily pill for 72 weeks lost 20% or more of their body weight.

Slimming injections have been revolutionary, but oral forms represent a major breakthrough because they simpler to store, distribute and take, and are also projected to be cheaper, providing fresh hope for millions trying to lose weight.

The medication is a GLP-1 agonist, a type of drug that aids in lowering blood sugar levels, delays the breakdown of food and can curb hunger.

Trial Findings and Convenience

Slimming results observed in people taking the tablet is not as dramatic as that among users taking tirzepatide, but experts believe the oral form is easier to obtain and user-friendly than injections.

Orforglipron is not yet approved by the US Food and Drug Administration or health authorities in other countries. The manufacturer has said it expects significant interest once the oral treatment is launched.

During the trial, the 3,127 patients were divided into cohorts receiving the medication pills of different strengths, while others received a dummy pill, for 72 weeks.

All of the volunteers had excess weight, indicating they had a BMI score of 30 or higher, but they were free from high blood sugar. Participants from multiple nations took part in the research.

Significant Results

Scientists discovered that following 72 weeks people on the smallest amount reduced an average of 7.5% of their weight. Participants on the maximum amount shed an average of 11.2% of their body weight.

In users taking the highest doses, more than half had a decrease of 10% or more of body weight, 36% had a reduction of 15% or greater, and almost one-fifth had a drop of 20% or higher.

Researchers said additional health metrics additionally got better among people using the drug, such as improved blood pressure, a reduced waist size and a decrease in bad cholesterol.

Frequent side-effects were gastrointestinal, which were said to be mild to moderate.

“In adults with obesity, long-term use using the medication resulted in significantly greater reductions in weight than placebo,” researchers wrote.

Potential Impact

Health leaders have praised weight loss treatments as transformative. But injections come with additional logistical efforts for medical systems, so oral options might benefit millions more people aiming to slim down.

Separate research shows weight loss injections may be effective on minors as young as six who have obesity or are diagnosed with diabetes. However, stomach problems were reported more frequently among young users taking the medications.

Experts emphasized that longer follow-up durations in future studies and additional practical analysis were crucial to determine the long-term impacts.”